Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorChemical name: 1-Phthalimidoxy-3,6,9,12-tetraoxapentadecan-15-oic acid succinimdyl ester // Synonyms: Phthaloyl-PEG(4)-NHS, 2,5-dioxopyrrolidin-1-yl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate
from €220.00
Spacer length 17 atoms or 19.0 A.
PEG reagent, which forms stable oxime conjugates useful in formation of glycolconjugates with oligonucleotides or protein-polysaccaride conjugates.
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag; PNAS 2009; 106: 3000-3005.
Site-Specific Modification of Recombinant Proteins: A Novel Platform for Modifying Glycoproteins Expressed in E. coli; G.E. Hendersen, K.D. Isett, T.U. Gerngross; Bioconjugate Chemistry 2011; 22: 903-912.
Synthesis of Oligonucleotide Glycoconjugates Inside a Glass Capillary through Oximation Ligations; Bioconjugate Chemistry 2010; 21: 748-755.
Efficient Surface Patterning of Oligonucleotide Glycoconjugates Inside a Glass Capillary through Oxime Bond Formation; N. Dendane, A. Hoang, L. Guillard, E. Defrancq, F. Vinet. P. Dumy; Bioconjugate Chemistry 2007; 18: 671-676.
Versatile and efficient synthesis of protein-polysaccharide conjugate vaccines using aminooxy reagents and oxime chemistry; A. Lees, G. Sen, A. Lopez Acosta; Vaccine 2006; 24: 716-729.
Please send me more information about